Notice: This company has been marked as potentially delisted and may not be actively trading. Bioanalytical Systems (BASI) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends BASI vs. NOTV, AIKI, LUNA, ONMD, BIAF, DKDCA, ISPC, IQV, ICLR, and INCYShould you be buying Bioanalytical Systems stock or one of its competitors? The main competitors of Bioanalytical Systems include Inotiv (NOTV), AIkido Pharma (AIKI), Luna Innovations (LUNA), OneMedNet (ONMD), bioAffinity Technologies (BIAF), Data Knights Acquisition (DKDCA), iSpecimen (ISPC), IQVIA (IQV), ICON Public (ICLR), and Incyte (INCY). Bioanalytical Systems vs. Inotiv AIkido Pharma Luna Innovations OneMedNet bioAffinity Technologies Data Knights Acquisition iSpecimen IQVIA ICON Public Incyte Inotiv (NASDAQ:NOTV) and Bioanalytical Systems (NASDAQ:BASI) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, media sentiment, dividends, profitability, risk, institutional ownership and community ranking. Do institutionals and insiders believe in NOTV or BASI? 18.2% of Inotiv shares are owned by institutional investors. Comparatively, 10.6% of Bioanalytical Systems shares are owned by institutional investors. 7.8% of Inotiv shares are owned by insiders. Comparatively, 11.5% of Bioanalytical Systems shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has more volatility & risk, NOTV or BASI? Inotiv has a beta of 3.58, suggesting that its share price is 258% more volatile than the S&P 500. Comparatively, Bioanalytical Systems has a beta of 1.92, suggesting that its share price is 92% more volatile than the S&P 500. Does the MarketBeat Community believe in NOTV or BASI? Bioanalytical Systems received 109 more outperform votes than Inotiv when rated by MarketBeat users. However, 48.72% of users gave Inotiv an outperform vote while only 37.10% of users gave Bioanalytical Systems an outperform vote. CompanyUnderperformOutperformInotivOutperform Votes1948.72% Underperform Votes2051.28% Bioanalytical SystemsOutperform Votes12837.10% Underperform Votes21762.90% Does the media refer more to NOTV or BASI? In the previous week, Inotiv had 9 more articles in the media than Bioanalytical Systems. MarketBeat recorded 9 mentions for Inotiv and 0 mentions for Bioanalytical Systems. Inotiv's average media sentiment score of 0.26 beat Bioanalytical Systems' score of 0.00 indicating that Inotiv is being referred to more favorably in the media. Company Overall Sentiment Inotiv Neutral Bioanalytical Systems Neutral Is NOTV or BASI more profitable? Bioanalytical Systems has a net margin of -7.75% compared to Inotiv's net margin of -25.40%. Inotiv's return on equity of -15.41% beat Bioanalytical Systems' return on equity.Company Net Margins Return on Equity Return on Assets Inotiv-25.40% -15.41% -3.58% Bioanalytical Systems -7.75%-42.74%-6.38% Which has better earnings & valuation, NOTV or BASI? Bioanalytical Systems has lower revenue, but higher earnings than Inotiv. Bioanalytical Systems is trading at a lower price-to-earnings ratio than Inotiv, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInotiv$490.74M0.28-$108.44M-$4.61-0.88Bioanalytical Systems$60.47M0.75-$4.68M-$0.35-11.60 Do analysts rate NOTV or BASI? Inotiv presently has a consensus price target of $5.92, indicating a potential upside of 45.73%. Given Inotiv's stronger consensus rating and higher possible upside, analysts clearly believe Inotiv is more favorable than Bioanalytical Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inotiv 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67Bioanalytical Systems 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryInotiv beats Bioanalytical Systems on 12 of the 18 factors compared between the two stocks. Get Bioanalytical Systems News Delivered to You Automatically Sign up to receive the latest news and ratings for BASI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BASI vs. The Competition Export to ExcelMetricBioanalytical SystemsCommercial Physical Research IndustryMedical SectorNASDAQ ExchangeMarket Cap$45.19M$4.09B$5.82B$9.13BDividend YieldN/A1.88%4.75%3.86%P/E Ratio-9.67120.2226.8119.20Price / Sales0.75248.14429.0769.62Price / Cash558.4031.5138.0134.83Price / Book5.883.037.644.62Net Income-$4.68M$118.81M$3.19B$246.06M Bioanalytical Systems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BASIBioanalytical SystemsN/A$4.06-4.5%N/A-31.8%$45.19M$60.47M-9.67397Analyst ForecastHigh Trading VolumeNOTVInotiv3.1751 of 5 stars$3.78+1.1%$5.92+56.5%-31.8%$98.32M$490.74M-0.822,075Insider TradeNews CoveragePositive NewsAIKIAIkido PharmaN/A$11.94-8.2%N/A+305.9%$65.49M$10,000.00-3.084Gap UpHigh Trading VolumeLUNALuna Innovations1.3983 of 5 stars$0.96+12.9%$8.00+733.3%-87.5%$32.60M$109.50M0.00390Upcoming EarningsAnalyst ForecastGap UpHigh Trading VolumeONMDOneMedNetN/A$0.93-3.0%N/A+26.8%$26.05M$957,651.000.002Gap UpBIAFbioAffinity Technologies2.3907 of 5 stars$0.81+0.6%$6.00+645.3%-41.5%$12.55M$9.37M-0.9810DKDCAData Knights AcquisitionN/A$0.93-3.0%N/A+26.8%$4.82MN/A-4.902ISPCiSpecimen0.7578 of 5 stars$1.86-4.6%N/A+303.7%$1.79M$10.39M-0.1060News CoverageIQVIQVIA4.9641 of 5 stars$193.65-1.2%$251.67+30.0%-22.8%$35.15B$15.41B25.8287,000Analyst ForecastPositive NewsICLRICON Public4.5941 of 5 stars$186.21+2.0%$283.92+52.5%-35.7%$15.36B$8.12B20.7641,100Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageINCYIncyte4.5261 of 5 stars$70.42+0.6%$75.59+7.3%+18.3%$13.57B$3.70B503.042,524 Related Companies and Tools Related Companies Inotiv Competitors AIkido Pharma Competitors Luna Innovations Competitors OneMedNet Competitors bioAffinity Technologies Competitors Data Knights Acquisition Competitors iSpecimen Competitors IQVIA Competitors ICON Public Competitors Incyte Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BASI) was last updated on 2/23/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNvidia > DeepSeekEveryone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioanalytical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bioanalytical Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
